The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
NGR-hTNF as second-line treatment in malignant pleural mesothelioma (MPM).
Gilda Rossoni
No relevant relationships to disclose
Vanesa Gregorc
No relevant relationships to disclose
Maria Grazia ViganĂ²
No relevant relationships to disclose
Alessandra Bulotta
No relevant relationships to disclose
Domenico Ghio
No relevant relationships to disclose
Antonio Lambiase
Employment or Leadership Position - MolMed S.p.A.
Claudio Bordignon
Employment or Leadership Position - MolMed S.p.A.